Why investing in women's health is good for business
Briefly

Preeclampsia leads to maternal and newborn deaths, yet its causes and cures remain unknown. Women face a health research gap, with just 1% of healthcare innovations focusing on female-specific conditions. Conditions affecting both genders often exclude women from clinical trials, limiting understanding of their health experiences. Affected conditions like endometriosis are widely misdiagnosed, contributing to women's longer duration in poor health despite their longer life expectancy. Addressing these issues is vital for gender equality and improving health outcomes globally.
Preeclampsia is a significant cause of death for mothers and newborns, with no known causes or cures, leading to immense suffering and loss.
Just 1% of healthcare research focuses on female-specific conditions beyond oncology, resulting in a lack of understanding and effective solutions.
Women are underrepresented in clinical trials, hindering our understanding of how common conditions uniquely affect them.
Despite living longer than men, women spend more time in poor health globally, exacerbated by a lack of research and misdiagnosis of conditions.
Read at Fortune
[
|
]